The State Department and U.S. Agency for International Development (USAID) released a “Joint Summary of Performance and Financial Information for FY 2012” summarizing the performance and accomplishments of the two agencies in fulfilling their diplomatic and development objectives, including efforts to address global health issues.
During remarks at the release of the World Health Organization’s (WHO) 2011 Global Tuberculosis Control Report, U.S. Agency for International Development (USAID) Assistant Administrator for Global Health Ariel Pablos-Mendez summarized USAID efforts to combat TB, HIV/TB co-infection, and drug resistant TB through initiatives such as the Global Health Initiative (GHI) and the President’s Emergency Plan for AIDS Relief (PEPFAR).
Senator Richard Blumenthal (D-CT) introduced S. 1734 – Generating Antibiotic Incentives Now Act of 2011. The bill provides incentives for the development of “antibiotic drug[s] for treating, detecting, preventing, or identifying a qualifying pathogen,” including, among other infectious agents, multi-drug resistant tuberculosis.
Learn more about the House companion bill (H.R. 2182).
UPDATE: The President signed the bill into law (Public Law #112-74) on December 23, 2011 after the Conference Agreement passed the House (296-121) on December 16, 2011 and the Senate (67-32) on December 17, 2011. Additionally, the Senate voted against (43-56) a resolution (H.Con.Res. 94) that would have applied a 1.83% across-the-board rescission to all FY 2012 appropriations except the Department of Defense (DoD), Military Construction, and Veterans Affairs.
Representative Hal Rogers (R-KY, 5th; Chairman House Committee on Appropriations) released a statement announcing that a joint House-Senate Conference Committee had reached agreement on final FY 2012 Appropriations legislation (H.R. 2055), which includes funding for global health programs through the State Department, U.S. Agency for International Development (USAID), the Department of Health and Human Services (HHS), and the Department of Defense (DoD). While total funding for the Global Health Initiative (GHI) is not yet available, the appropriations detailed in this agreement totaled $8.3 billion.
Directs that no FY 2012 global health funds may be used for needle exchange programs;
Includes additional Congressional oversight before the Administration makes a multi-year funding pledge;
Requires the Administration to report back to Congress with an analysis of the potential costs/savings of transitioning the Office of the Global AIDS Coordinator (OGAC) into USAID; and
Requires the Administration to report back to Congress with an analysis of transitioning the leadership of the Global Health Initiative (GHI) to USAID as outlined in the Quadrennial Diplomacy and Development Review (QDDR).
Global health appropriations as provided in the Conference Report (House Report 112-331) and Joint Statement of Managers are summarized as follows:
The Administration released “The United States Global Health Initiative: Strategy Document,” which includes information on the operational plan, targets, and implementation of the Global Health Initiative (GHI).
Secretary of State Hillary Clinton, U.S. Agency for International Development Administrator Dr. Rajiv Shah, and Dr. Christine Sizemore and Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) released statements commemorating World Tuberculosis (TB) Day and reaffirming the U.S. commitment to combating TB.
U.S. Global AIDS Coordinator Ambassador Eric Goosby and U.S. Agency for International Development (USAID) Deputy Assistant Administrator for Global Health Amie Batson testified before the House Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs on the FY 2012 budget request for global health and HIV/AIDS.
Among other things, the proposed resolution states that the House of Representatives “supports the goals of World TB Day to raise awareness about tuberculosis” and “reaffirms its commitment to global tuberculosis control made through the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008.”
Representative Harold Rogers (R-KY, 5th) introduced the “Department of Defense and Full-Year Continuing Appropriations Act, 2011” (H.R. 1473) authorizing appropriations for the remaining six months of FY 2011 (the first 6 months of FY 2011 were funded under FY 2010 levels). The proposed funding totals for global health (as compared to FY 2010 totals) included in this appropriations bill are provided in the table below.
Note: The appropriations bill (H.R. 1473) includes an across-the-board rescission of 0.2 percent to all discretionary spending; the global health funding totals for FY 11 (H.R. 1473) listed below include this rescission.
Timeline of the bill:
- Introduced and referred to the House Committee on the Budget and the House Committee on Ways and Means on April 11, 2011.
- Passed by the House (260-167) and the Senate (81-19) on April 14, 2011.
- Signed by the President (Public Law No: 112-10) on April 15, 2011.
The proposed bill would impose a 0.005% tax on the value of the currency (if greater than $10,000 USD) acquired in a currency exchange transaction. The revenue generated by this tax would be directed to three new trust funds established at the Department of the Treasury: 10% would be directed to a “Child Care Assistance Trust Fund,” 25% to a “Multilateral Global Health Trust Fund,” and 25% to a “Global Climate Change Adaptation and Mitigation Trust Fund.” The remainder would be directed to federal budget deficit reduction or reduction of the federal debt.
The Secretary of State would have authority to provide grants from the Multilateral Global Health Trust Fund to entities such as the Global Fund to Fight AIDS, Tuberculosis and Malaria and other multilateral organizations that meet specific criteria outlined in the bill. The bill also states that funding for the multilateral organizations must be in addition to and not replacing existing funding and should be used for the purposes of “addressing HIV/AIDS, tuberculosis, malaria, maternal mortality, family planning, neglected diseases, and other health issues affecting developing countries.”